Gene therapy has emerged as a revolutionary approach to treating genetic disorders by directly addressing underlying genetic abnormalities. However, the success of gene therapy hinges on the efficient and safe delivery of therapeutic genes to target cells. Traditional viral vectors, despite their high transfection efficiency, face limitations such as immunogenicity, limited cargo capacity, and risks of insertional mutagenesis. Non-viral gene delivery systems, particularly those based on macromolecular carriers, have gained prominence as safer and more versatile alternatives. This review explores the advancements in synthetic and natural polymer-based gene delivery systems, highlighting their design, mechanisms, and therapeutic potential.
Role of Macromolecules in Gene Delivery Systems
Macromolecular carriers, including synthetic and natural polymers, offer significant advantages such as biocompatibility, controlled gene release, and targeted delivery. These systems are categorized into various types, such as cationic polymers, dendrimers, and hybrid nanomaterials, each with unique physicochemical properties that influence their gene delivery efficiency. Compared to viral vectors, non-viral systems exhibit lower immunogenicity and greater design flexibility, making them suitable for diverse therapeutic applications.
Targeting Strategies of Macromolecules for Non-viral Gene Therapy
Functional polymers can be engineered with targeting ligands or stimuli-responsive elements to enhance specificity and efficiency. Natural polymers like chitosan, hyaluronic acid (HA), and dextran are particularly notable for their biodegradability and low toxicity. For example, chitosan's pH-sensitive behavior and mucoadhesive properties make it ideal for oral and nasal delivery, while HA's affinity for CD44 receptors enables tumor-specific targeting. Synthetic polymers, such as polyethyleneimine (PEI) and poly(L-lysine) (PLL), are widely used for their strong nucleic acid binding and endosomal escape capabilities but often require modifications to reduce cytotoxicity.
Cationic Polymers
Cationic polymers, including PEI, PLL, and poly(β-amino ester)s (PBAEs), play a crucial role in gene delivery by forming stable polyplexes with nucleic acids. PEI's high charge density facilitates efficient transfection, but its cytotoxicity necessitates modifications like PEGylation. PBAEs, known for their biodegradability and pH-responsive properties, have shown promise in delivering plasmid DNA and RNA molecules with minimal toxicity. Dendritic polymers, such as poly(amidoamine) (PAMAM) dendrimers, offer precise structures and high transfection efficiency but require optimization to balance efficacy and safety.
Conjugation-Based and Star Polymers
Conjugation-based systems, like polyplex micelles, integrate hydrophobic cores and PEG shells to improve circulation time and targeting. Star polymers, with their branched architectures, exhibit high gene-loading capacity and enhanced cellular uptake. For instance, star-shaped PEI-g-PEG polymers have demonstrated reduced toxicity and improved transfection efficiency in retinoblastoma therapy.
Comb and Brush Polymers
Comb polymers, with their hydrophobic backbones and oligolysine side chains, provide efficient gene transport and protection. Brush polymers, particularly those with PEG-based structures, enhance nuclease stability and cellular uptake, making them suitable for siRNA delivery. These architectures highlight the importance of polymer design in achieving optimal gene delivery outcomes.
Limitations and Future Perspectives
Despite their potential, polymer-based gene delivery systems face challenges such as lower transfection efficiency compared to viral vectors, cytotoxicity, and batch-to-batch variability. Future research aims to develop "smart" polymers that respond to cellular stimuli, integrate multifunctional components for targeted delivery, and leverage natural polymers for improved biocompatibility. Advances in nanotechnology and hybrid systems are expected to overcome physiological barriers, such as the blood-brain barrier, further expanding therapeutic applications.
Conclusions
Macromolecular gene delivery systems represent a promising frontier in non-viral gene therapy, offering a balance of safety, versatility, and efficacy. By addressing current limitations through innovative polymer design and targeted strategies, these systems hold the potential to revolutionize the treatment of genetic disorders and complex diseases like cancer. Continued research and preclinical studies will be essential to translate these advancements into clinical practice.
Full text
https://www.xiahepublishing.com/2572-5505/JERP-2025-00009
The study was recently published in the Journal of Exploratory Research in Pharmacology .
Journal of Exploratory Research in Pharmacology (JERP) publishes original innovative exploratory research articles, state-of-the-art reviews, editorials, short communications that focus on novel findings and the most recent advances in basic and clinical pharmacology, covering topics from drug research, drug development, clinical trials and application.
